Clinical trial of etanercept tapering in juvenile idiopathic arthritis during remission

Juvenile idiopathic arthritis

(2011) Berent Prakken et al.   LANCET

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

(2011) Timothy Beukelman et al.   ARTHRITIS CARE & RESEARCH

Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical Trial

(2010) Dirk Foell   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis

(2010) V. Bejarano et al.   RHEUMATOLOGY

Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis

(2010) V. Papsdorf et al.   RHEUMATOLOGY

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis

(2009) F H M Prince et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis

(2009) E. H. Giannini et al.   ARTHRITIS AND RHEUMATISM

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

(2008) S M van der Kooij et al.   ANNALS OF THE RHEUMATIC DISEASES

Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis

(2008) P Tynjala et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

(2008) F H M Prince et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

(2008) G Horneff et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

(2008) Daniel J. Lovell et al.   ARTHRITIS AND RHEUMATISM